Tang Capital Management’s Immunocore IMCR Stock Holding History

Tang Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$79.9M	Buy	2,649,368 +20,830	+0.8%	+$674K	4.06%	13
2025 Q4	$91.2M	Buy	2,628,538 +322,930	+14%	+$11.4M	4.51%	8
2025 Q3	$83.8M	Buy	2,305,608 +200,000	+9%	+$6.79M	3.22%	7
2025 Q2	$66.1M	Buy	2,105,608 +189,900	+10%	+$5.9M	3.34%	4
2025 Q1	$56.8M	Buy	1,915,708 +360,108	+23%	+$10.8M	3.14%	7
2024 Q4	$45.9M	Buy	1,555,600 +450,000	+41%	+$14.2M	3.04%	7
2024 Q3	$34.4M	Buy	1,105,600 +700,000	+173%	+$25.5M	2.46%	8
2024 Q2	$13.7M	Hold	405,600	–	–	1.4%	24
2024 Q1	$26.4M	Hold	405,600	–	–	2.75%	7
2023 Q4	$27.7M	Hold	405,600	–	–	2.56%	10
2023 Q3	$21.1M	Hold	405,600	–	–	2.97%	9
2023 Q2	$24.3M	Hold	405,600	–	–	3.58%	5
2023 Q1	$20.1M	Hold	405,600	–	–	2.99%	9
2022 Q4	$23.1M	Hold	405,600	–	–	3.36%	8
2022 Q3	$19M	Buy	405,600 +20,000	+5%	+$953K	2.33%	13
2022 Q2	$14.4M	Hold	385,600	–	–	2.18%	15
2022 Q1	$11.5M	Buy	+385,600	New	+$9.73M	2.31%	12

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Tang Capital Management's IMCR Position: Q1 2026 in Review

Tang Capital Management increased its Immunocore (IMCR) stake by 0.79% in Q1 2026, buying an estimated $674K and bringing the position to 2,649,368 shares worth $79.9M. The position accounts for 4.06% of the portfolio, ranked #13.

Tang Capital Management first reported a position in IMCR in Q1 2022 and has held it in 17 quarters since. The position peaked at $91.2M in Q4 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Tang Capital Management held 2,649,368 shares of Immunocore worth $79.9M as of Q1 2026.
Tang Capital Management bought 20,830 Immunocore shares in Q1 2026, an estimated $674K.
Immunocore made up 4.06% of Tang Capital Management's portfolio in Q1 2026, its #13 holding.
Tang Capital Management first reported a position in Immunocore in Q1 2022 and has held it in 17 quarters since.
Tang Capital Management's Immunocore position peaked at $91.2M in Q4 2025.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.